Remove Circulation Remove Congenital Remove Congenital Heart Disease
article thumbnail

Atrial Fibrillation Ablation in Congenital Heart Disease: Therapeutic Challenges and Future Perspectives

Journal of the American Heart Association

Journal of the American Heart Association, Ahead of Print. The increasing prevalence of atrial fibrillation (AF) in adults with congenital heart disease raises significant questions regarding its management. Emerging imaging modalities and ablation techniques might have a role to play.

article thumbnail

Neurodevelopmental Outcomes for Individuals With Congenital Heart Disease: Updates in Neuroprotection, Risk-Stratification, Evaluation, and Management: A Scientific Statement From the American Heart Association

Circulation

Circulation, Ahead of Print. Over the past decade, new research has advanced scientific knowledge of neurodevelopmental trajectories, factors that increase neurodevelopmental risk, and neuroprotective strategies for individuals with congenital heart disease.

article thumbnail

Abstract 4147236: Healing Hearts Mending Minds: Battling Anxiety and Depression in adults with congenital heart disease.

Circulation

Circulation, Volume 150, Issue Suppl_1 , Page A4147236-A4147236, November 12, 2024. Background/Introduction:Adults with congenital heart disease have higher rates of anxiety, depression, and suicide, compared to those without congenital heart disease.

article thumbnail

Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart Association

Circulation

Circulation, Ahead of Print. Wearable biosensors (wearables) enable continual, noninvasive physiologic and behavioral monitoring at home for those with pediatric or congenital heart disease. Wearables allow patients to access their personal data and monitor their health.

article thumbnail

Creative concepts article: Potential applications of ultrasound-based leadless endocardial pacing in adult congenital heart disease

HeartRhythm

Cardiac device therapy is frequently required for individuals with adult congenital heart disease (ACHD), whether it be for bradyarrhythmia, ventricular tachyarrhythmia, or cardiac resynchronization therapy (CRT).

article thumbnail

Latest research redefines neurodevelopmental risks, outcomes for congenital heart disease

Medical Xpress - Cardiology

More than a decade of new knowledge about neurodevelopmental risk in people with congenital heart disease has changed the thinking about who is most at risk and the factors that impact neurological development, learning, emotions and behaviors, according to a new American Heart Association statement published in Circulation.

article thumbnail

Evaluation and Management of Chronic Heart Failure in Children and Adolescents With Congenital Heart Disease: A Scientific Statement From the American Heart Association

Circulation

Circulation, Ahead of Print. With continued medical and surgical advancements, most children and adolescents with congenital heart disease are expected to survive to adulthood.